BMS-345541

Source: Wikipedia, the free encyclopedia.
BMS-345541
Identifiers
  • 4-(2′-Aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline
JSmol)
  • n1c3c(n2c(cnc2c1NCCN)C)cc(cc3)C
  • InChI=1S/C14H17N5/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18) ☒N
  • Key:PSPFQEBFYXJZEV-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

BMS-345541, developed by

transcription in mice.[1]

It has no approvals for human/medical use or for use in clinical trials. No clinical trials mention it.[2]

References

  1. ^ The Journal of Biological Chemistry. 2003. 278. 1450-1456.
  2. ^ no studies found for: BMS-345541